These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37806253)

  • 1. BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells.
    Kahm YJ; Kim RK
    Biochem Biophys Res Commun; 2023 Nov; 682():141-147. PubMed ID: 37806253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of KIF4A on Cancer Stem Cells and EMT in Lung Cancer and Glioma.
    Kahm YJ; Kim IG; Jung U; Lee JH; Kim RK
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer.
    Szczyrek M; Mlak R; Szudy-Szczyrek A; Wojas-Krawczyk K; Kędziora K; Milanowski J
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in Lung Adenocarcinoma Cells.
    Zhang Q; Chen X; Hu Y; Zhou T; Du M; Xu R; Chen Y; Tang P; Chen Z; Li J
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BIRC5 Expression is Regulated in Uterine Epithelium During the Estrous Cycle.
    Cho M; Lee OH; Chang EM; Lee S; Moon S; Lee J; Park H; Park KH; Park C; Hong K; Choi Y
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32155884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.
    Zhao G; Wang Q; Gu Q; Qiang W; Wei JJ; Dong P; Watari H; Li W; Yue J
    Oncotarget; 2017 Nov; 8(55):94666-94680. PubMed ID: 29212257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Involvement of
    Gil-Kulik P; Krzyżanowski A; Dudzińska E; Karwat J; Chomik P; Świstowska M; Kondracka A; Kwaśniewska A; Cioch M; Jojczuk M; Nogalski A; Kocki J
    Oxid Med Cell Longev; 2019; 2019():8727925. PubMed ID: 30774747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma.
    Kahm YJ; Kim IG; Kim RK
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircCAMSAP1 promotes non-small cell lung cancer proliferation and inhibits cell apoptosis by sponging miR-1182 and regulating BIRC5.
    Wang Y; Li X; Wang H; Zhang G
    Bioengineered; 2022 Feb; 13(2):2428-2439. PubMed ID: 35132928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
    Cao Y; Zhu W; Chen W; Wu J; Hou G; Li Y
    Dis Markers; 2019; 2019():5451290. PubMed ID: 31093306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations.
    Zu Y; Ban J; Xia Z; Wang J; Cai Y; Ping W; Sun W
    Biochem Biophys Res Commun; 2013 Jan; 430(2):529-34. PubMed ID: 23232114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells.
    Lin TY; Chan HH; Chen SH; Sarvagalla S; Chen PS; Coumar MS; Cheng SM; Chang YC; Lin CH; Leung E; Cheung CHA
    Autophagy; 2020 Jul; 16(7):1296-1313. PubMed ID: 31612776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.
    Greiner J; Brown E; Bullinger L; Hills RK; Morris V; Döhner H; Mills KI; Guinn BA
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
    Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
    Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between functional variants in BIRC5/survivin gene 3' untranslated region and mRNA expression in lymphoblastoid cell lines.
    Pu F; Shao Z; Yang S; Liu J; Lin S; Ma X; Yang H
    Oncol Lett; 2015 Oct; 10(4):2319-2322. PubMed ID: 26622842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
    Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.
    Wang B; Li X; Zhao G; Yan H; Dong P; Watari H; Sims M; Li W; Pfeffer LM; Guo Y; Yue J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):235. PubMed ID: 30241553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00511 Knockdown Suppresses Resistance to Cisplatin in Lung Adenocarcinoma by Interacting with miR-182-3p and BIRC5.
    Zhu Z; Shi Y; Gong X; Li J; Zhang M
    Mol Biotechnol; 2022 Mar; 64(3):252-262. PubMed ID: 34595724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Expression of
    Gil-Kulik P; Świstowska M; Kondracka A; Chomik P; Krzyżanowski A; Kwaśniewska A; Rahnama M; Kocki J
    Oxid Med Cell Longev; 2020; 2020():9084730. PubMed ID: 32322338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.